Clinical trial
VEGF Trap in Treating Patients With Metastatic Breast Cancer
NCT00369655 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00369655 |
|---|---|
| Title | VEGF Trap in Treating Patients With Metastatic Breast Cancer |
| Official title | Phase II Trial of VEGF Trap in Patients With Metastatic Breast Cancer Previously Treated With Anthracycline and/or Taxane |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer |
| Intervention type | Biological |
| Interventions | ziv-aflibercept |
| Enrollment | 21 |
| Start date | Jan 1, 2007 |
| Primary completion | Mar 1, 2008 |
| Completion | Jan 1, 2011 |
| First posted | Aug 29, 2006 |
| Last update posted | May 5, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: